Dataset Information


D-2-Hydroxyglutarate in Glioma Biology.

ABSTRACT: Isocitrate dehydrogenase (IDH) mutations are common genetic abnormalities in glioma, which result in the accumulation of an "oncometabolite", D-2-hydroxyglutarate (D-2-HG). Abnormally elevated D-2-HG levels result in a distinctive pattern in cancer biology, through competitively inhibiting α-ketoglutarate (α-KG)/Fe(II)-dependent dioxgenases (α-KGDDs). Recent studies have revealed that D-2-HG affects DNA/histone methylation, hypoxia signaling, DNA repair, and redox homeostasis, which impacts the oncogenesis of IDH-mutated cancers. In this review, we will discuss the current understanding of D-2-HG in cancer biology, as well as the emerging opportunities in therapeutics in IDH-mutated glioma.

PROVIDER: S-EPMC8464856 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| E-MTAB-11328 | BioStudies
| S-EPMC4385911 | BioStudies
| S-EPMC4746092 | BioStudies
| S-EPMC4694633 | BioStudies
| S-EPMC6520482 | BioStudies
| S-EPMC7554955 | BioStudies
| S-EPMC4663076 | BioStudies
| S-EPMC4962051 | BioStudies
2013-01-01 | S-EPMC3698461 | BioStudies
| S-EPMC4521140 | BioStudies